6533b827fe1ef96bd1286831
RESEARCH PRODUCT
Curative therapies for hepatocellular carcinoma: an update and perspectives.
Roberto EggenhöffnerValeria MismasGiampaolo BresciMaurizio RainieriE. TuminoAntonio RomanoMichela AntonucciLuca GiacomelliRodolfo SaccoGiuseppe CabibboAmbra Cortisubject
RFASurgical resectionAblation TechniquesPathologymedicine.medical_specialtyPercutaneousCarcinoma HepatocellularAblative therapymedicine.medical_treatmentLiver transplantationResection03 medical and health sciences0302 clinical medicinemedicineHepatectomyHumansPharmacology (medical)resectionHCCAblative therapy; early stage; HCC; liver transplant; PEI; resection; RFA; Ablation Techniques; Carcinoma Hepatocellular; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Oncology; Pharmacology (medical)business.industryCarcinomaLiver NeoplasmsHepatocellularearly stagemedicine.diseasedigestive system diseasesPEISurgeryLiver Transplantationliver transplantOncology030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyLiver cancerbusinessdescription
Curative treatments, including liver transplantation, surgical resection and percutaneous treatments, are the recommended therapies in BCLC-0 (Barcelona Clinic of Liver Cancer) or BCLC-A hepatocellular carcinoma (HCC). This review provides an overview of some issues of clinical importance concerning curative treatments in HCC.
year | journal | country | edition | language |
---|---|---|---|---|
2015-12-14 | Expert review of anticancer therapy |